Abiopharma

New Form SCHEDULE 13G/A - agilon health, inc. Filed: 2025-10-30 AccNo: 0000102909-25-000063 Size: 6 KB

New Form SCHEDULE 13G - ABEONA THERAPEUTICS INC. Filed: 2025-10-30 AccNo: 0000102909-25-000059 Size: 6 KB

New Form SCHEDULE 13G/A - AGENUS INC Filed: 2025-10-30 AccNo: 0000102909-25-000038 Size: 6 KB

New Form SCHEDULE 13G/A - Avidity Biosciences, Inc. Filed: 2025-10-30 AccNo: 0000102909-25-000039 Size: 6 KB

Deadline Alert: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

(99% Positive) PMGC Holdings Inc. (ELAB) Announces Business Combination

New Form SCHEDULE 13G - Avalo Therapeutics, Inc. Filed: 2025-10-30 AccNo: 0000102909-25-000035 Size: 6 KB

New Form SCHEDULE 13G/A - ACCURAY INC Filed: 2025-10-30 AccNo: 0000102909-25-000029 Size: 6 KB

New Form SCHEDULE 13G/A - 10x Genomics, Inc. Filed: 2025-10-30 AccNo: 0000102909-25-000030 Size: 6 KB

New Form SCHEDULE 13G - ArriVent BioPharma, Inc. Filed: 2025-10-30 AccNo: 0000102909-25-000025 Size: 6 KB

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Nkarta to Participate in November Investor Conferences

New Form DEFA14A - Nuo Therapeutics, Inc. Filed: 2025-10-30 AccNo: 0001437749-25-032359 Size: 360 KB

New Form DEF 14A - Nuo Therapeutics, Inc. Filed: 2025-10-30 AccNo: 0001437749-25-032357 Size: 1 MB